Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GOVX | US
-0.09
-4.29%
Healthcare
Biotechnology
30/06/2024
17/10/2024
2.01
2.12
2.12
2.00
GeoVax Labs Inc. a clinical-stage biotechnology company develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19) human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses such as Ebola Sudan Marburg and Lassa as well as therapeutic vaccines for HIV chronic Hepatitis B infections and solid tumor cancers. The company is developing GEO-CM04S1 a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin a novel patented product/technology for the treatment of solid tumors and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02 a pan-coronavirus vaccine. In addition it is also developing GEO-ZM02 a vaccine candidate which is in preclinical trial for the treatment of GEO-ZM02 a vaccine candidate which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses such as Ebola Sudan and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs Inc. was incorporated in 1988 and is headquartered in Smyrna Georgia.
View LessLow Debt to Equity (< 0.25)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
91.5%1 month
82.3%3 months
273.7%6 months
262.6%-
10.63
129.50
-0.06
0.03
0.10
52.84
-
-27.16M
17.15M
17.15M
-
-1.68K
-
-100.00
-362.39
0.28
3.55
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.41
Range1M
1.27
Range3M
9.58
Rel. volume
0.40
Price X volume
534.03K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Minerva Neurosciences Inc | NERV | Biotechnology | 2.58 | 18.04M | -3.37% | n/a | -194.60% |
Cognition Therapeutics Inc. Common Stock | CGTX | Biotechnology | 0.4456 | 17.88M | -0.49% | n/a | 2.71% |
Inhibikase Therapeutics Inc. | IKT | Biotechnology | 2.35 | 17.54M | 21.13% | n/a | 3.49% |
Kazia Therapeutics Limited | KZIA | Biotechnology | 0.5269 | 17.54M | 58.04% | n/a | 6.82% |
Athira Pharma Inc | ATHA | Biotechnology | 0.4477 | 17.21M | -1.52% | n/a | 1.69% |
ICU | ICU | Biotechnology | 4.02 | 16.85M | -4.29% | n/a | -45.50% |
IN8bio Inc. Common Stock | INAB | Biotechnology | 0.2301 | 16.69M | 0.52% | n/a | 43.30% |
Synlogic Inc | SYBX | Biotechnology | 1.42 | 16.61M | -1.39% | n/a | 0.00% |
Can-Fite BioPharma Ltd | CANF | Biotechnology | 2.7 | 16.46M | 0.00% | n/a | 0.64% |
Evaxion Biotech A/S | EVAX | Biotechnology | 2.71 | 15.99M | 0.00% | n/a | 837.11% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.10 | 0.53 | Cheaper |
Ent. to Revenue | 52.84 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 129.50 | 15.30 | Expensive |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 273.69 | 72.92 | Riskier |
Debt to Equity | -0.06 | -1.24 | Expensive |
Debt to Assets | 0.03 | 0.25 | Cheaper |
Market Cap | 17.15M | 3.78B | Emerging |